FI913909A0 - Stabilisering av t-PA pro - Google Patents

Stabilisering av t-PA pro

Info

Publication number
FI913909A0
FI913909A0 FI913909A FI913909A FI913909A0 FI 913909 A0 FI913909 A0 FI 913909A0 FI 913909 A FI913909 A FI 913909A FI 913909 A FI913909 A FI 913909A FI 913909 A0 FI913909 A0 FI 913909A0
Authority
FI
Finland
Prior art keywords
stabilization
pro
compound
disclosed
enzymatic activity
Prior art date
Application number
FI913909A
Other languages
English (en)
Finnish (fi)
Other versions
FI96000C (sv
FI96000B (sv
Inventor
Ulrich Kohnert
Rainer Rudolph
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI913909A0 publication Critical patent/FI913909A0/sv
Application granted granted Critical
Publication of FI96000B publication Critical patent/FI96000B/sv
Publication of FI96000C publication Critical patent/FI96000C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
FI913909A 1989-12-20 1991-08-19 Stabilisering av t-PA pro FI96000C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3942143A DE3942143A1 (de) 1989-12-20 1989-12-20 T-pa pro stabilisierung
DE3942143 1989-12-20
EP9002251 1990-12-19
PCT/EP1990/002251 WO1991008766A1 (de) 1989-12-20 1990-12-19 t-PA pro STABILISIERUNG

Publications (3)

Publication Number Publication Date
FI913909A0 true FI913909A0 (sv) 1991-08-19
FI96000B FI96000B (sv) 1996-01-15
FI96000C FI96000C (sv) 1996-04-25

Family

ID=6395926

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913909A FI96000C (sv) 1989-12-20 1991-08-19 Stabilisering av t-PA pro

Country Status (13)

Country Link
US (1) US5352453A (sv)
EP (1) EP0458939B1 (sv)
JP (1) JPH0657661B2 (sv)
KR (1) KR920700684A (sv)
AT (1) ATE103178T1 (sv)
AU (1) AU633684B2 (sv)
CA (1) CA2046929C (sv)
DE (2) DE3942143A1 (sv)
FI (1) FI96000C (sv)
HU (2) HU208637B (sv)
LV (1) LV10199B (sv)
NO (1) NO305583B1 (sv)
WO (1) WO1991008766A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
JPH06506459A (ja) * 1991-04-16 1994-07-21 ロシュ ダイアグノスティックス ゲーエムベーハー プラスミノーゲン活性化剤を含有する多重ボーラス投与用医薬パッケージユニット
DE69322268T2 (de) * 1992-04-30 1999-08-05 Cor Therapeutics Inc Stabile zusammensetzung von polypeptiden
US6001480A (en) * 1993-06-11 1999-12-14 Zexel Corporation Amorphous hard carbon film and mechanical parts coated therewith
DE4405426A1 (de) * 1994-02-21 1995-08-24 Boehringer Mannheim Gmbh Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
DE3687255T2 (de) * 1985-09-10 1993-05-06 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
JPH0678241B2 (ja) * 1986-04-02 1994-10-05 エーザイ株式会社 ｔＰＡ医薬組成物
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
WO1990001333A1 (en) * 1988-08-02 1990-02-22 Invitron Corporation METHOD FOR PREPARING tPA COMPOSITIONS
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
JPH0813750B2 (ja) * 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤

Also Published As

Publication number Publication date
NO913118D0 (no) 1991-08-09
KR920700684A (ko) 1992-08-10
EP0458939A1 (de) 1991-12-04
FI96000C (sv) 1996-04-25
NO305583B1 (no) 1999-06-28
LV10199A (lv) 1994-10-20
ATE103178T1 (de) 1994-04-15
AU7037591A (en) 1991-07-18
HU912742D0 (en) 1992-01-28
DE59005128D1 (de) 1994-04-28
JPH03505465A (ja) 1991-11-28
WO1991008766A1 (de) 1991-06-27
NO913118L (no) 1991-08-09
AU633684B2 (en) 1993-02-04
EP0458939B1 (de) 1994-03-23
DE3942143A1 (de) 1991-06-27
LV10199B (en) 1995-04-20
HUT59610A (en) 1992-06-29
HU208637B (en) 1993-12-28
CA2046929A1 (en) 1991-06-21
US5352453A (en) 1994-10-04
CA2046929C (en) 1997-01-14
FI96000B (sv) 1996-01-15
JPH0657661B2 (ja) 1994-08-03

Similar Documents

Publication Publication Date Title
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
MX9206008A (es) Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
AU3183389A (en) Human relaxin formulation
FI925787A (fi) Proteolytiska enzymers sackarinderivatinhibitorer
MY102929A (en) Aqueous pharmaceutical formulations of piroxicam monohydrate
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
ES2060357T3 (es) Estabilizacion de k2p pro.
NO882454D0 (no) Plasminogen-aktivator.
FI913909A0 (sv) Stabilisering av t-PA pro
MD1360C2 (ro) Compoziţie fungicidă, procedeu de combatere şi prevenire a infectării cu Oomicete a plantelor
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
IT8322486A0 (it) N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
KR920700683A (ko) t-PA의 가용화
IT1216103B (it) Peptidi ad attivita' farmaceutica.
SU1828577A3 (ru) Состав, стимулирующий лейкопоэз
IT8420355A0 (it) Derivato del p-aminofenolo conattivita'mucosecretolitica-fluidificante e antipiretica, procedimento per lasua preparazione e sue composizioni farmaceutiche.

Legal Events

Date Code Title Description
BB Publication of examined application